Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis: Sodium channel blocker protects axons in MS models.
Driving performance in persons with mild to moderate symptoms of multiple sclerosis.
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
[Chronic cough and worsening dyspnea: a case of idiopathic tracheal stenosis].
Expanded Disability Status Scale-Based Disability and Dental-Periodontal Conditions in Patients with Multiple Sclerosis.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
New treatments for multiple sclerosis: at what long-term risk?
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Age-associated changes in rat immune system: Lessons learned from experimental autoimmune encephalomyelitis.
[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
Differential microRNA expression in blood in multiple sclerosis.
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies.
Improving the quality of mental health care in Multiple Sclerosis.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
Polymorphisms of the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis.
Computer-based diagnosis of illness in historical persons.
Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
Reports of Patients and Relatives from the CogniCIS Study about Cognition in Clinically Isolated Syndrome: What Are Our Patients Telling Us?
Preliminary results after upper cervical chiropractic care in patients with chronic cerebro-spinal venous insufficiency and multiple sclerosis.
Functional organization of an Mbp enhancer exposes striking transcriptional regulatory diversity within myelinating glia.
William Austin Sibley, MD (1925-2015).
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Age-Dependent Decline of Nogo-A Protein in the Mouse Cerebrum.
Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.

Pages